BSX Financial Facts

Net income (loss) per common share - assuming dilution: 0.15
Intangible asset impairment charges: 0
See Full Income Statement

See Full Balance Sheet

Boston Scientific (BSX) Earnings

  |   Expand Research on BSX
Next EPS Date 10/28/16 *Est. EPS Growth Rate +22.7% *Last Qtr.
Average EPS % Beat Rate +6.3% Revenue Growth Rate +15.4% *Last Qtr.
Average % Move 1-Wk after EPS +4.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/28/16 Q216 $0.27$0.27 $0.00$2.13B$2.05B Details
4/27/16 Q116 $0.28$0.24 +$0.04$1.96B$1.91B Details
2/4/16 Q415 $0.26$0.25 +$0.01$1.98B$1.99B Details
10/28/15 Q315 $0.24$0.23 +$0.01$1.89B$1.86B = Details
7/23/15 Q215 $0.22$0.21 +$0.01$1.84B$1.83B = Details
4/28/15 Q115 $0.21$0.21 $0.00$1.77B$1.78B = Details
2/4/15 Q414 $0.22$0.21 +$0.01$1.89B$1.91B = Details
10/22/14 Q314 $0.20$0.20 $0.00$1.85B$1.82B Details